Intravenous steroid for severe facial shingles pain
Part of Infections, Pain clinical trials.
This trial tests a steroid medication given through an IV to reduce pain from shingles on the face. It aims to help people with severe pain that has lasted less than three months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a shingles rash for less than 90 days.
- The rash is on your face (trigeminal nerve area).
- You are between 18 and 75 years old.
- Your pain is severe (7 or higher on a 0–10 pain scale).
- You have more than 4 tender spots on your skin.
- You are not pregnant, breastfeeding, or using immunosuppressants, and you do not have severe diseases like cancer or autoimmune disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a two-step procedure for treating nerve pain after shingles (called postherpetic neuralgia). First, a special type of radiofrequency treatment is applied to block the pain signals. Then, a long-lasting numbing medicine is injected under the skin to help keep the pain away. It is for people aged 40 to 85 who have not gotten enough relief from standard medicines.
This trial tests whether adding esketamine (a medicine related to ketamine) to a standard nerve treatment (pulsed radiofrequency) can better relieve face pain caused by shingles. It may help if you have ongoing, moderate-to-severe pain in your face or scalp.
This trial tests if desvenlafaxine (an antidepressant also used for nerve pain) can safely reduce pain from shingles. It may be an option if your shingles pain is moderate to severe and started within the last 3 months.
This trial tests whether adding a medication called esketamine to a standard nerve procedure (pulse radiofrequency) can better reduce facial pain from shingles. Esketamine may help block pain signals more effectively.
This trial tests a new medicine called crisugabalin to see if it safely reduces shingles pain. It may help if you have moderate to severe pain from a shingles rash that started less than 3 months ago.
This study tests whether adding a medicine called esketamine to a standard nerve block procedure can improve pain relief for people with shingles-related nerve pain. If you have had shingles pain for less than 3 months, this might help reduce pain and prevent long-term discomfort.
Hear when a new Herpes Zoster Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.